ArticleTranslational oncology2019

Novel Therapeutic Anti-ADAM17 Antibody A9(B8) Enhances EGFR-TKI-Mediated Anticancer Activity in NSCLC.

Zheng Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.